New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B

Author： Huang Yina H Hoebe Kasper Sauer Karsten

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.4, 2008-04, pp. : 391-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 3, 2003-06 ,pp. : 191-200

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C isozymes as potential therapeutic targets in immune disorders

By Lee Matthew R Duan Wei Tan Seng-Lai

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 535-552

Informa Healthcare

Access to resources Recommend Favorite

Trends in the Exploration of Therapeutic Targets for the Treatment of Endocrine, Metabolic and Immune Disorders

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 225-231

Bentham Science Publishers

Access to resources Recommend Favorite

Co-stimulatory molecules B7-1 and B7-2 as experimental therapeutic targets

By Zheng P. Liu Y.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 93-108

Informa Healthcare

Access to resources Recommend Favorite

New Treatment Targets and Approaches for Hepatitis B Virus

Anti-Infective Agents, Vol. 15, Iss. 1, 2017-04 ,pp. : 4-8

Bentham Science Publishers

Access to resources Recommend Favorite